Processa Pharmaceuticals, Inc. Stock Issued During Period, Value, Acquisitions
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Processa Pharmaceuticals, Inc. stock issued during period, value, acquisitions for the quarter ending 2024-03-31 was $189.00K.
- Processa Pharmaceuticals, Inc. stock issued during period, value, acquisitions for fiscal 2024 was $189.00K.
- Processa Pharmaceuticals, Inc. stock issued during period, value, acquisitions for fiscal 2022 was $400.00K, a 42.86% decline from fiscal 2021.
- Processa Pharmaceuticals, Inc. stock issued during period, value, acquisitions for fiscal 2021 was $700.00K, a 91.03% decline from fiscal 2020.
- Processa Pharmaceuticals, Inc. stock issued during period, value, acquisitions for fiscal 2020 was $7.80M.
| Period end | Stock Issued During Period, Value, Acquisitions 3 month | Stock Issued During Period, Value, Acquisitions 12 month |
|---|---|---|
| 2024-12-31 | $189.00K 10-K · filed 2025-03-20 | |
| 2024-03-31 | $189.00K 10-Q · filed 2025-11-06 | |
| 2022-12-31 | $400.00K 10-K · filed 2024-03-29 | |
| 2021-12-31 | $700.00K 10-K · filed 2023-03-30 | |
| 2020-12-31 | $7.80M 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |